Dubious $56,000 Alzheimer’s drug spurs largest Medicare price hike ever
arstechnica.com
arstechnica.com
When will they ever get what's coming to them? One must wonder...
Things are really starting to feel like France at the turn of the 18th century.
It is probably best to accept that there is no such thing as Karma in life. We don't live in a Hollywood blockbuster where the good guys win all the time no matter what the odds.
That's almost twice of the entire NHS healthcare spending for one drug that probably doesn't do anything for Alzheimer patients? This isn't actually going through at the end of the day right? The US healthcare, drug and regulatory system has lost the plot, that's just nuts.
And what on earth is going on at the FDA to approve this? Even if I was a literal pharma lobbyist I would probably skip that one because it just sounds too wrong
Whether or not taxpayers should pay for a certain treatment for a certain population is a political excercise, usually implemented via CMS, but also state Medicaid departments.
This really requires some fix at the FDA or somewhere in the government or it's going to be a disaster.
https://blogs.sciencemag.org/pipeline/archives/2021/07/02/th...
But it's 12% of all Medicare premiums
If I understand it right, that's what other countries do. Countries with universal healthcare systems are basically the only buyer, and can drive a hard bargain. Yet the US needs for-profit middle-men, that can't seem to get a price as good other countries...but yet they're supposed to perform better than Medicare? Doesn't make any sense (to an outsider)
https://en.wikipedia.org/wiki/Medicare_Prescription_Drug,_Im...
"You shot yourself in the foot"
"Oh, yeah, right. I forgot."
Pharmaceutical companies bribe—sorry, lobby—members of Congress so those members of Congress vote against letting Medicare negotiate pricing.
Since money is speech, (see Citizens United v FEC) the one with the most money wins.
Other developed countries have a variety of systems, but they typically do at least have a public option (available to all).
US middle men are not trying to get a good price.
US consensus failures on this are based on fear of the government, entrenched interests, lack of inspiration on what specifically to change, coincidental convenience as the status quo keeps people preoccupied and risk averse, and a large very sick population that really would massively increase taxpayer costs in the first several years no matter how it would equalize in a longer term.
However, the government, by law, demands stiff discounts anyways. Medicare only pays the average of what other customers pay.
Then stack on the 340B law and drug companies give the government substantial discounts on the back end.
Now you opened up the balance of cost and effectiveness. Therein lies the nest of vipers.